Light Chain Amyloidosis Clinical Trials in Nanjing, Jiangsu
2 recruitingNanjing, Jiangsu, China
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients
Systemic Light Chain Amyloidosis
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.70 enrolled23 locationsNCT07266116
Recruiting
Phase 1
FKC288 for Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Light Chain Amyloidosis
Nanjing University School of Medicine12 enrolled1 locationNCT05978661